Hydrangenol Composition for Inhibiting Fat Formation and Reducing Body Fat
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for obesity are ineffective, and there is a need for accessible, long-term solutions to inhibit fat formation and reduce body fat, as obesity rates continue to rise despite medical and biological research efforts.
Innovation Solution
A composition containing hydrangenol, which reduces the expression of adipogenic factors such as PPARγ, thereby inhibiting triglyceride accumulation and secretion, is used in health functional foods and pharmaceutical compositions to prevent or treat obesity and related metabolic diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional obesity treatments are used, then medical intervention is provided, but treatment effectiveness is insufficient and obesity rates continue to rise
Solution Approach 1:
The patent changes the molecular target parameter from conventional obesity treatments to PPARγ, a key adipogenic factor. By specifically targeting and reducing PPARγ expression through hydrangenol, the patent achieves more effective obesity treatment with better reliability and higher obesity reduction rate
Solution Approach 2:
The patent extracts and isolates hydrangenol as the active ingredient from hydrangea plants, focusing on this specific compound's ability to inhibit PPARγ expression. This extraction allows for targeted obesity treatment that is more effective than conventional approaches
2Ease of operation
If individual behavior change is induced to prevent obesity, then lifestyle modification is achieved, but this approach is not perfect for individuals with busy lives in complex industrial societies
Solution Approach 1:
The patent introduces hydrangenol as an intermediary substance that mediates between diet and obesity prevention. Instead of relying solely on individual behavior change, hydrangenol acts as a biological mediator that inhibits fat formation mechanisms, making obesity prevention more accessible and reliable for busy individuals
Solution Approach 2:
The patent substitutes the mechanical/lifestyle approach (diet and exercise) with a biochemical mechanism (PPARγ inhibition by hydrangenol). This replacement provides a more reliable and accessible obesity prevention method that does not require significant lifestyle modification
3Loss of information
If basic medical and biological research on obesity is developed, then scientific understanding is improved, but obesity rates continue to increase indicating a gap between research and reality
Solution Approach 1:
The patent applies self-service by using naturally occurring hydrangenol from hydrangea plants to address obesity. This approach leverages nature's own compounds to solve the obesity problem, bridging the gap between research knowledge and real-world effectiveness without requiring complex medical interventions
Data Source
AI summary
Provided is a composition for inhibiting fat formation and reducing body fat, the composition including hydrangenol as an active ingredient.The composition of the present disclosure reduces fat accumulation in adipocytes, reduces phosphorylation of mammalian target of rapamycin (mTOR), and increases phosphorylation of forkhead box O1 (FoxO1), and finally, leading to reduction of an expression level of peroxisome proliferator-activated receptor gamma γ (PPAR), and as a result, the composition inhibits formation of triglyceride in adipocytes to exhibit an anti-obesity effect. Accordingly, the composition including hydrangenol disclosed herein as an active ingredient may be usefully applied to the fields of health functional foods or cosmetics for inhibiting fat formation.